Bradley J PhD Bolzon Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bradley J PhD Bolzon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bradley J PhD Bolzon. Bradley J PhD Bolzon is Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Monte Rosa Therapeutics, Inc. ($GLUE).
Bradley J PhD Bolzon in CRISPR Therapeutics AG
Trading Symbol: CRSPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Bradley J PhD Bolzon: Director
Holdings: 57,149 shares
Current Value: $900,097
Latest Transaction: Mar 24 2021
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Bradley J PhD Bolzon in CRISPR Therapeutics AG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDTX, CRSP, GLUE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 134.93 | 300 | 40,478 | 30,375 | 30.7 K to 30.4 K (-0.98 %) |
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 134.33 | 5,237 | 703,495 | 30,675 | 35.9 K to 30.7 K (-14.58 %) |
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 133.28 | 9,334 | 1,244,070 | 35,912 | 45.2 K to 35.9 K (-20.63 %) |
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 132.53 | 6,090 | 807,092 | 45,246 | 51.3 K to 45.2 K (-11.86 %) |
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 131.14 | 2,400 | 314,741 | 51,336 | 53.7 K to 51.3 K (-4.47 %) |
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 130.42 | 3,413 | 445,112 | 53,736 | 57.1 K to 53.7 K (-5.97 %) |
Mar 24 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 129.36 | 3,600 | 465,678 | 57,149 | 60.7 K to 57.1 K (-5.93 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 565 | 0 | 60,749 | 60.2 K to 60.7 K (+0.94 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 4,012 | 0 | 0 | 4 K to 0 (-100.00 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 4,012 | 0 | 4,012 | 0 to 4 K |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 18,574 | 0 | 44,295 | 62.9 K to 44.3 K (-29.54 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 12,648 | 0 | 60,184 | 47.5 K to 60.2 K (+26.61 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 56,056 | 0 | 0 | 56.1 K to 0 (-100.00 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 1,755 | 0 | 56,056 | 54.3 K to 56.1 K (+3.23 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 8,126 | 0 | 18,457 | 26.6 K to 18.5 K (-30.57 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 1,585 | 0 | 54,301 | 52.7 K to 54.3 K (+3.01 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 7,341 | 0 | 16,625 | 24 K to 16.6 K (-30.63 %) |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 52,716 | 0 | 52,716 | 0 to 52.7 K |
Mar 03 2021 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 244,056 | 0 | 581,999 | 826.1 K to 582 K (-29.54 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 151.05 | 931 | 140,625 | 339,834 | 340.8 K to 339.8 K (-0.27 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 151.05 | 969 | 146,365 | 0 | 969 to 0 (-100.00 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 150.14 | 958 | 143,837 | 340,765 | 341.7 K to 340.8 K (-0.28 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 150.14 | 995 | 149,392 | 969 | 2 K to 969 (-50.66 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 149.12 | 2,009 | 299,586 | 341,723 | 343.7 K to 341.7 K (-0.58 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 149.12 | 2,091 | 311,815 | 1,964 | 4.1 K to 2 K (-51.57 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 148.28 | 2,576 | 381,972 | 343,732 | 346.3 K to 343.7 K (-0.74 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 148.28 | 2,679 | 397,245 | 4,055 | 6.7 K to 4.1 K (-39.78 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 147.00 | 878 | 129,068 | 346,308 | 347.2 K to 346.3 K (-0.25 %) |
Dec 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 147.00 | 914 | 134,360 | 6,734 | 7.6 K to 6.7 K (-11.95 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 144.85 | 15,900 | 2,303,155 | 314,186 | 330.1 K to 314.2 K (-4.82 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 143.26 | 2,223 | 318,462 | 330,086 | 332.3 K to 330.1 K (-0.67 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 142.42 | 5,958 | 848,562 | 332,309 | 338.3 K to 332.3 K (-1.76 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 141.54 | 6,648 | 940,923 | 338,267 | 344.9 K to 338.3 K (-1.93 %) |
Dec 14 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 140.62 | 2,271 | 319,345 | 344,915 | 347.2 K to 344.9 K (-0.65 %) |
Nov 02 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 18,477 | 0 | 40,648 | 22.2 K to 40.6 K (+83.34 %) |
Nov 02 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 2,433 | 0 | 7,922 | 10.4 K to 7.9 K (-23.50 %) |
Nov 02 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 105,681 | 0 | 0 | 105.7 K to 0 (-100.00 %) |
Nov 02 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 105,681 | 0 | 105,681 | 0 to 105.7 K |
Nov 02 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 410,405 | 0 | 1,336,088 | 1.7 M to 1.3 M (-23.50 %) |
Sep 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 14,780 | 0 | 22,171 | 7.4 K to 22.2 K (+199.97 %) |
Sep 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 1,948 | 0 | 10,355 | 12.3 K to 10.4 K (-15.83 %) |
Sep 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 84,544 | 0 | 0 | 84.5 K to 0 (-100.00 %) |
Sep 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 84,544 | 0 | 84,544 | 0 to 84.5 K |
Sep 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 328,324 | 0 | 1,746,493 | 2.1 M to 1.7 M (-15.82 %) |
Sep 22 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 86.87 | 3,035 | 263,636 | 518,190 | 521.2 K to 518.2 K (-0.58 %) |
Sep 18 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 86.98 | 8,965 | 779,777 | 521,225 | 530.2 K to 521.2 K (-1.69 %) |
Sep 16 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 84.89 | 1,155 | 98,045 | 530,190 | 531.3 K to 530.2 K (-0.22 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 85.90 | 8,684 | 745,930 | 531,345 | 540 K to 531.3 K (-1.61 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 85.90 | 8,684 | 745,930 | 531,345 | 540 K to 531.3 K (-1.61 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 85.03 | 14,161 | 1,204,066 | 540,029 | 554.2 K to 540 K (-2.56 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 85.03 | 14,161 | 1,204,066 | 540,029 | 554.2 K to 540 K (-2.56 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 7,391 | 0 | 7,391 | 0 to 7.4 K |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 7,391 | 0 | 7,391 | 0 to 7.4 K |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 42,272 | 0 | 0 | 42.3 K to 0 (-100.00 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 42,272 | 0 | 0 | 42.3 K to 0 (-100.00 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 42,272 | 0 | 42,272 | 0 to 42.3 K |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 42,272 | 0 | 42,272 | 0 to 42.3 K |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 974 | 0 | 12,303 | 13.3 K to 12.3 K (-7.34 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 974 | 0 | 12,303 | 13.3 K to 12.3 K (-7.34 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 164,162 | 0 | 2,074,817 | 2.2 M to 2.1 M (-7.33 %) |
Sep 11 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 164,162 | 0 | 2,074,817 | 2.2 M to 2.1 M (-7.33 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | M | 59.31 | 15,000 | 889,650 | 15,000 | |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | M | 13.62 | 15,000 | 204,300 | 15,000 | |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | M | 14.00 | 30,000 | 420,000 | 30,000 | |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 93.74 | 200 | 18,748 | 0 | 200 to 0 (-100.00 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 92.98 | 19,135 | 1,779,256 | 200 | 19.3 K to 200 (-98.97 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 92.40 | 36,365 | 3,360,162 | 19,335 | 55.7 K to 19.3 K (-65.29 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 91.27 | 4,300 | 392,477 | 55,700 | 60 K to 55.7 K (-7.17 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | M | 59.31 | 15,000 | 889,650 | 60,000 | 45 K to 60 K (+33.33 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | M | 13.62 | 15,000 | 204,300 | 45,000 | 30 K to 45 K (+50.00 %) |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | M | 14.00 | 30,000 | 420,000 | 30,000 | 0 to 30 K |
Jul 08 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 83.00 | 5,311 | 440,810 | 554,190 | 559.5 K to 554.2 K (-0.95 %) |
Jul 08 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 82.16 | 14,689 | 1,206,920 | 559,501 | 574.2 K to 559.5 K (-2.56 %) |
Jun 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 75.35 | 10,000 | 753,453 | 574,190 | 584.2 K to 574.2 K (-1.71 %) |
Jun 24 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 72.51 | 10,000 | 725,069 | 584,190 | 594.2 K to 584.2 K (-1.68 %) |
Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
Nov 21 2019 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 67.41 | 28,255 | 1,904,783 | 596,741 | 625 K to 596.7 K (-4.52 %) |
Nov 21 2019 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 67.41 | 13,745 | 926,605 | 0 | 13.7 K to 0 (-100.00 %) |
Nov 01 2019 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.89 | 21,000 | 1,089,675 | 13,745 | 34.7 K to 13.7 K (-60.44 %) |
Jun 13 2019 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 43.52 | 15,000 | 652,800 | 15,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 59.31 | 30,000 | 1,779,300 | 30,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 59.31 | 30,000 | 1,779,300 | 30,000 | |
May 17 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 58.73 | 1,000 | 58,730 | 640,014 | 641 K to 640 K (-0.16 %) |
May 17 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 57.97 | 43,000 | 2,492,710 | 641,014 | 684 K to 641 K (-6.29 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.38 | 2,900 | 149,002 | 34,745 | 37.6 K to 34.7 K (-7.70 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.16 | 6,341 | 318,065 | 37,645 | 44 K to 37.6 K (-14.42 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.26 | 582 | 29,833 | 90,730 | 91.3 K to 90.7 K (-0.64 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.26 | 249 | 12,764 | 38,772 | 39 K to 38.8 K (-0.64 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.26 | 225 | 11,534 | 34,977 | 35.2 K to 35 K (-0.64 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.26 | 7,645 | 391,883 | 1,192,139 | 1.2 M to 1.2 M (-0.64 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.31 | 7,424 | 373,501 | 91,312 | 98.7 K to 91.3 K (-7.52 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.31 | 3,172 | 159,583 | 39,021 | 42.2 K to 39 K (-7.52 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.31 | 2,862 | 143,987 | 35,202 | 38.1 K to 35.2 K (-7.52 %) |
May 09 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.31 | 97,550 | 4,907,741 | 1,199,784 | 1.3 M to 1.2 M (-7.52 %) |
May 02 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.29 | 2,044 | 102,793 | 98,736 | 100.8 K to 98.7 K (-2.03 %) |
May 02 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.26 | 874 | 43,927 | 42,193 | 43.1 K to 42.2 K (-2.03 %) |
May 02 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.29 | 788 | 39,629 | 38,064 | 38.9 K to 38.1 K (-2.03 %) |
May 02 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.29 | 26,860 | 1,350,789 | 1,297,334 | 1.3 M to 1.3 M (-2.03 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.03 | 779 | 38,973 | 100,780 | 101.6 K to 100.8 K (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.03 | 779 | 38,973 | 100,780 | 101.6 K to 100.8 K (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.01 | 333 | 16,653 | 43,067 | 43.4 K to 43.1 K (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.01 | 333 | 16,653 | 43,067 | 43.4 K to 43.1 K (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.08 | 300 | 15,024 | 38,852 | 39.2 K to 38.9 K (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.08 | 300 | 15,024 | 38,852 | 39.2 K to 38.9 K (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.02 | 10,236 | 512,005 | 1,324,194 | 1.3 M to 1.3 M (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.02 | 10,236 | 512,005 | 1,324,194 | 1.3 M to 1.3 M (-0.77 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.11 | 14,086 | 705,849 | 101,559 | 115.6 K to 101.6 K (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.11 | 14,086 | 705,849 | 101,559 | 115.6 K to 101.6 K (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.12 | 6,019 | 301,672 | 43,400 | 49.4 K to 43.4 K (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.12 | 6,019 | 301,672 | 43,400 | 49.4 K to 43.4 K (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.12 | 5,430 | 272,152 | 39,152 | 44.6 K to 39.2 K (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.12 | 5,430 | 272,152 | 39,152 | 44.6 K to 39.2 K (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.11 | 185,075 | 9,274,108 | 1,334,430 | 1.5 M to 1.3 M (-12.18 %) |
Apr 30 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.11 | 185,075 | 9,274,108 | 1,334,430 | 1.5 M to 1.3 M (-12.18 %) |
Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.00 | 1,528 | 77,928 | 115,645 | 117.2 K to 115.6 K (-1.30 %) |
Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.00 | 653 | 33,303 | 49,419 | 50.1 K to 49.4 K (-1.30 %) |
Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.60 | 589 | 29,803 | 44,582 | 45.2 K to 44.6 K (-1.30 %) |
Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.00 | 20,071 | 1,023,621 | 1,519,505 | 1.5 M to 1.5 M (-1.30 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.66 | 6,821 | 345,552 | 117,173 | 124 K to 117.2 K (-5.50 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.00 | 2,915 | 148,665 | 50,072 | 53 K to 50.1 K (-5.50 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 51.00 | 2,630 | 134,130 | 45,171 | 47.8 K to 45.2 K (-5.50 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 50.66 | 89,628 | 4,540,554 | 1,539,576 | 1.6 M to 1.5 M (-5.50 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 16,262 | 0 | 43,986 | 27.7 K to 44 K (+58.66 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 92,918 | 0 | 0 | 92.9 K to 0 (-100.00 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 92,918 | 0 | 92,918 | 0 to 92.9 K |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 2,947 | 0 | 13,277 | 16.2 K to 13.3 K (-18.16 %) |
Apr 24 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 497,053 | 0 | 2,238,979 | 2.7 M to 2.2 M (-18.17 %) |
Dec 27 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 20.30 | 26,016 | 528,237 | 27,724 | 53.7 K to 27.7 K (-48.41 %) |
Nov 28 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 20.24 | 200 | 4,048 | 53,740 | 53.9 K to 53.7 K (-0.37 %) |
Nov 28 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 20.21 | 1,507 | 30,450 | 53,940 | 55.4 K to 53.9 K (-2.72 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 55,447 | 0 | 55,447 | 0 to 55.4 K |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 1,240 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 1,240 | 0 | 1,240 | 0 to 1.2 K |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 17,283 | 0 | 0 | 17.3 K to 0 (-100.00 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 17,283 | 0 | 17,283 | 0 to 17.3 K |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 292,529 | 0 | 0 | 292.5 K to 0 (-100.00 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | J | 0.00 | 292,529 | 0 | 292,529 | 0 to 292.5 K |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 26,491 | 0 | 52,987 | 79.5 K to 53 K (-33.33 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 61,993 | 0 | 123,994 | 186 K to 124 K (-33.33 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 23,899 | 0 | 47,801 | 71.7 K to 47.8 K (-33.33 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 814,599 | 0 | 1,629,204 | 2.4 M to 1.6 M (-33.33 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 8,110 | 0 | 16,224 | 24.3 K to 16.2 K (-33.33 %) |
Sep 07 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | J | 0.00 | 1,368,013 | 0 | 2,736,032 | 4.1 M to 2.7 M (-33.33 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 5,774 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 13,180 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 5,210 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 173,167 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 1,454 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 231,077 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 73,704 | 0 | 0 |